Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim + Liposomal Amphotericin B for Invasive Fungal Infection
NCT00003315Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Jul 1997
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of sargramostim in invasive fungal infection (IFI), sponsored by Medical Research Council. Started Jul 1997; status: completed.
02
Drugs
sargramostim
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00003315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003315.